The Scantox Group is Scandinavia’s leading contract research organization (CRO) within the preclinical of the Life Science industry. The company performs contract-based research for manufacturers within the medical industry (pharma / medico / biotech). This research is essential for the further development of new drugs.
Head Office is located in Denmark (in Ejby, Lille Skensved, close to Køge), currently employing a staff of over 130 from a wide range of different academic / educational backgrounds as well as with a broad range of different competencies. In addition the Scantox Group includesf two subsidiaries in Sweden. Originally founded in 1977, the Scantox Group is today owned by the Nordic investment company Impilo, providing a solid platform to enables rapid and ambitious growth – nationally as well as internationally.